| Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers A Ghorbani, MK Chatanaka, LM Avery, M Wang, J Brown, R Cohen, ... Clinical Proteomics 21 (1), 41, 2024 | | 2024 |
| RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups NK Leclair, A Choudury, WC Chen, ST Magill, K McCortney, CM Horbinski, ... Neuro-Oncology, noae150, 2024 | | 2024 |
| Diagnostic utility of multimodal advanced molecular testing to classify metastases of unknown primaries: A case of a patient with no known medical history H Smith, J Jean, D Duckett, E Vormittag-Nocito, BG Nezami, LJ Jennings, ... Journal of Neuropathology & Experimental Neurology, nlae086, 2024 | | 2024 |
| Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated BBB opening: A novel combinatorial immunotherapy regimen for gliomas KS Kim, K Habashy, A Gould, J Zhao, H Najem, C Amidei, R Saganty, ... Neuro-Oncology, noae135, 2024 | | 2024 |
| Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy A Choudhury, MA Cady, CHG Lucas, H Najem, JJ Phillips, B Palikuqi, ... Cancer Discovery, OF1-OF15, 2024 | 1 | 2024 |
| Optimizing the use of Ki-67 proliferative index as a prognostic biomarker in meningiomas using digital analysis V Thirunavu, M Drumm, M McCord, A Steffens, MW Youngblood, ... Journal of Neurosurgery 1 (aop), 1-11, 2024 | | 2024 |
| Transdifferentiation of metastatic melanoma into cerebellar angiosarcoma N Kostelecky, N Wadhwani, I Golubovich, E Vormittag-Nocito, J Gao, ... Journal of Neuropathology & Experimental Neurology, nlae075, 2024 | | 2024 |
| Long-term outcomes of central neurocytoma–an institutional experience Y Yang, N Wadhwani, A Shimomura, S Zheng, J Chandler, MS Lesniak, ... Journal of Neuro-Oncology, 1-7, 2024 | | 2024 |
| STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma H Najem, ST Lea, S Tripathi, L Hurley, CH Chen, I William, M Sooreshjani, ... The Journal of Clinical Investigation 134 (12), 2024 | | 2024 |
| Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas VA Arrieta, A Gould, KS Kim, KJ Habashy, C Dmello, ... Nature Communications 15 (1), 4698, 2024 | 3 | 2024 |
| RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma X Song, D Tiek, S Miki, T Huang, M Lu, A Goenka, R Iglesia, X Yu, R Wu, ... The Journal of clinical investigation 134 (11), 2024 | | 2024 |
| GR. 6 Meningioma molecular classification predicts response to surgery and adjuvant radiotherapy: an integrated clinicomolecular analysis & prospective validation JZ Wang, AP Landry, V Patil, J Liu, A Ajisebutu, AC Gadol, C Wilson, ... Canadian Journal of Neurological Sciences 51 (s1), S2-S2, 2024 | | 2024 |
| Predictors of salvage therapy for parasagittal meningiomas treated with primary surgery, radiosurgery, or surgery plus adjuvant radiotherapy SJ Trybula, KR Nandoliya, MW Youngblood, CL Karras, LG Fernandez, ... Journal of Clinical Neuroscience 124, 102-108, 2024 | | 2024 |
| Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma): A Unique Treatment Approach for a Rare Central Nervous System Tumor L Singer, J Singer, C Horbinski, M Penas-Prado, RV Lukas The Neurologist, 10.1097, 2024 | | 2024 |
| IDH inhibition in gliomas: from preclinical models to clinical trials R Rudà, C Horbinski, M van den Bent, M Preusser, R Soffietti Nature Reviews Neurology, 1-13, 2024 | | 2024 |
| Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution CHG Lucas, K Mirchia, K Seo, H Najem, WC Chen, N Zakimi, K Foster, ... Nature Genetics, 1-13, 2024 | 1 | 2024 |
| The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care SJ Trybula, MW Youngblood, CL Karras, NK Murthy, AB Heimberger, ... Cancers 16 (9), 1753, 2024 | | 2024 |
| 494 Evaluating ERK1 2 Phosphorylation as a Predictive Biomarker for Survival in Recurrent Glioblastoma Patients: A REMARK Criteria-guided Analysis of a Clinical Trial Cohort … VA Arrieta, J Duerinck, KB Burdett, W Geens, JK Schwarze, A Gould, ... Neurosurgery 70 (Supplement_1), 151, 2024 | | 2024 |
| Characterization of Immune Cell Heterogeneity, Key B Cell Subtypes, and Macrophages Functions Using Multiplex Immunofluorescence and Single-cell RNA Sequencing in Chordomas VA Arrieta, JK Benotmane, J Zhao, S Dhiantravan, D Hou, JL Katz, ... Neurosurgery 70 (Supplement_1), 202-203, 2024 | | 2024 |
| Blood-Brain Barrier Opening with Ultrasound Augments Doxorubicin and Anti-PD-1 Therapy Efficacy, Intracranial Immune Activation, and Prolongs Survival in Preclinical Glioma Models VA Arrieta, A Gould, KS Kim, K Habashy, C Dmello, C Amidei, CG Gómez, ... Neurosurgery 70 (Supplement_1), 207, 2024 | | 2024 |
C. David JamesProfessor Emeritus, Feinberg School of Medicine, Northwestern UniversityVerified email at northwestern.edu